We have an immediate opening for a postdoctoral fellow/staff scientist in cellular engineering!
The Millman Laboratory is looking for a motivated scientist to join the team to study and improve differentiation of human pluripotent stem cells to pancreatic insulin-producing β cells for the study and treatment of diabetes. If interested, email your CV and cover letter to email@example.com
The major focus of the Millman laboratory is the in vitro production and study of pancreatic insulin-producing β cells from human pluripotent stem cells for use in cellular replacement therapy and drug screening. The rapid rise in the occurrence of diabetes mellitus has garnered much attention in the development of technologies to better study and treat this disease. As diabetes is caused by the destruction or dysfunction of insulin-producing pancreatic β cells, much of this focus has been directed to the generation of human β cells in vitro, for without this capability, further advancement in disease modeling, drug screening, and transplantation are precluded.
Dr. Millman with colleagues developed a 6-step protocol for generating functional pancreatic β cells in vitro from human pluripotent stem cells. These cells, called stem cell-derived β cells (SC-β cells), have similar physiological function of adult β cells as assessed by numerous in vitro and in vivo assays. Upon transplantation, these insulin-producing cells rapidly reverse hyperglycemia in diabetic mice. We are able to generate these cells in highly-scalable suspension culture, producing up to half a billion cells per batch.
The Millman laboratory is investigating methods to improve the generation, function, and utility of SC-β cells, primarily by using biomedical engineering approaches to introduce and modulate microenvironmental cues that play an important role in β cell development and function. These methods are also being extended to investigate SC-β cells generated from diabetic patients using induced pluripotent stem cells (iPS cells).
Stem Cell Technology for Scalable SC-β Cell Production
The methods found in the Millman laboratory afford the ability to produce large quantities of human pluripotent stem cells and SC-β cells. Cells are grown in scalable suspension culture as clusters approximately the size of an islet in disposable spinner flasks. Up to half a billion cells, of which almost half produce insulin, can be produced per flask using this approach. Suspension culture has the additional advantage of providing a three-dimensional environment to better mimic in vivo development.
The goal of Millman laboratory is for these cells to one day be used in cell replacement therapy to treat diabetic patients by transplanting these exogenous cells to replace the function lost by the endogenous β cells. We hope to accomplish this through a multidisciplinary approach combining stem cell technology, biomedical engineering approaches, and islet biology.
Tissue Engineering the Islet Microenvironment
Genome Engineering of Human Pluripotent Stem Cells
Study of Diabetic Patient-Derived SC-β Cells
†Jeffrey R. Millman and †Felicia W. Pagliuca. Autologous Pluripotent Stem Cell–Derived β-Like Cells for Diabetes Cellular Therapy. Diabetes 66(5):1111-1120 (2017). Article link
Jiwon Song and Jeffrey R. Millman. Economic 3D-Printing Approach for Transplantation of Stem Cell-Derived β Cells. Biofabrication 9(1), 015002 (2016). Article link
†Jeffrey R. Millman, Chunhui Xie, Alana van Dervort, Mads Gürtler, Felicia W. Pagliuca, and †Douglas A. Melton. Generation of stem cell-derived β cells from patients with type 1 diabetes. Nature Communications 7, 11463 (2016). Article link
Arturo J. Vegas, Omid Veiseh, Mads Gürtler, Jeffrey R. Millman, Felicia W. Pagliuca, Andrew R. Bader, Joshua C. Doloff, Jie Li, Michael Chen, Karsten Olejnik, Hok Hei Tam, Siddharth Jhunjhunwala, Erin Langan, Stephanie Aresta-Dasilva, Srujan Gandham, James J. McGarrigle, Matthew A. Bochenek, Jennifer Hollister-Lock, Jose Oberholzer, Dale L. Greiner, Gordon C.Weir, Douglas A. Melton, Robert Langer, Daniel G. Anderson. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nature Medicine 22(3), 306-11 (2016). Article link
**Felicia W. Pagliuca, **Jeffrey R. Millman, **Mads Gurtler, Michael Segel, Alana Van Dervort, Jennifer Hyoje Ryu, Quinn P. Peterson, Dale Greiner, Douglas A. Melton. Generation of Functional Human Pancreatic β Cells In Vitro. Cell 159, 428-39 (2014). Article link
Siniša Hrvatin, Charles W. O’Donnell, Francis Deng, Jeffrey R. Millman, Felicia W. Pagliuca, Philip DiIorio, Alireza Rezania, David K. Gifford, Douglas A. Melton. Differentiated Human Stem Cells Resemble Fetal, Not Adult β Cells. Proceedings of the National Academy of Sciences 111(8), 3038-43 (2014). Article link
**Daryl E. Powers, **Jeffrey R. Millman, Michael Rappel, Clark K. Colton. Accurate control of oxygen level in cells during culture on silicone rubber membranes with application to stem cell differentiation. Biotechnology Progress 26(3), 805-18 (2010). Article link
**Jeffrey R. Millman, **Jit Hin Tan, Clark K. Colton. The effects of low oxygen on self-renewal and differentiation of embryonic stem cells. Current Opinions in Organ Transplantation 14(6), 694-700 (2009). Article link
**Renita Horton, **Jeffrey R. Millman, Clark K. Colton, Debra Auguste. Engineering microenvironments for embryonic stem cell differentiation to cardiomyocytes. Regenerative Medicine 4(5), 721-32 (2009). Article link
Daryl E. Powers, Jeffrey R. Millman, Ryan B. Huang, Clark K. Colton. Effects of oxygen on mouse embryonic stem cell growth, phenotype retention, and cellular energetics. Biotechnology and Bioengineering 101, 241-54 (2008). Article link
Jeffrey R. Millman, Ketan H. Bhatt, Brian G. Prevo, Orlin D. Velev. Anisotropic particle synthesis in dielectrophoretically controlled microdroplet reactors. Nature Materials 4, 98-102 (2005). Article link
Clark K. Colton, Daryl E. Powers, Jeffrey R. Millman. Methods and Compositions for Enhanced Differentiation from Embryonic Stem Cells. Patent No. 9,029,147. Issued May 12, 2015.
Clark K. Colton, Jeffrey R. Millman. Methods and compositions for increased safety of stem cell-derived populations. Patent No. 9,388,381. Issued July 12, 2016.
Clark K. Colton, Amanda R. DiIenno, Jeffrey R. Millman. Method for Differentiating Human Embryonic Stem Cells into β-cells for the Treatment of Type 1 Diabetes. Patent No. 9,447,378. Issued September 20, 2016.
Jeffrey R. Millman, Jiwon Song. 3D-PRINTED SCAFFOLD DEVICE FOR CELL TRANSPLANTATION. Patent Application No. 62410760. October 20, 2016
Douglas A. Melton, Jeffrey R. Millman. METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF. Patent Application No. 62/093,999. Filed December 18, 2015.
Douglas A. Melton, Jeffrey R. Millman. METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF. Patent Application No. 14/975,255. Filed December 18, 2015.
Douglas A. Melton, Jeffrey R. Millman, Mads Gurtler. METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED β CELLS AND USES THEREOF. Patent Application No. 62/093,942. Filed December 18, 2015.
Jeffrey R. Millman, Quinn P. Peterson, Douglas A. Melton. SC-α CELLS AND METHODS FOR GENERATING AND USING THE SAME. Provisional Patent Application No. 62/093,942. Filed September 25, 2015.
Quinn P. Peterson, Felicia W. Pagliuca, Douglas A. Melton, Jeffrey R. Millman, Michael Segel, Mads Gurtler. SC-β Cells and Compositions and Methods for Generating the Same. Patent Application No. 14/684,129. Filed April 10, 2015.
Laboratory Contact Information
838 Southwest Tower (Medical campus)
660 S. Euclid Ave.
Campus Box 8127
St. Louis, MO 63110
Phone: (314) 362-3347
Fax: (314) 362-7641
Jeffrey R. Millman, Ph.D.
Assistant Professor of Medicine and Biomedical Engineering
Dr. Millman received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology in 2011, where he studied the effects of controlled oxygen exposure on stem cell differentiation with Dr. Clark Colton. He completed his postdoctoral research fellowship at Harvard University with Dr. Douglas Melton, developing methods to generate functional pancreatic insulin-producing β cells from human stem cells, and received a Harvard Stem Cell Institute Postdoctoral Fellowship. Dr. Millman joined the Department of Medicine faculty at Washington University in St. Louis in 2015.
Nathaniel Hogrebe, Ph.D.
Postdoctoral Research Fellow
Nathaniel earned his bachelor’s degree in Chemical Engineering from the University of Dayton and completed his PhD in Biomedical Engineering at The Ohio State University. His doctoral research focused on the importance of insoluble cues from the cellular microenvironment on certain cell behaviors, such as human mesenchymal stem cell differentiation. He joined the Millman Lab in November 2016 with the hopes of using these skills to help improve SC-β cell differentiation and assist in the tissue engineering of pancreatic islets. Outside of the lab, Nathaniel has a good time participating in a variety of sports such as tennis and ice hockey, playing the piano, and enjoying the outdoors.
Stefanie Shahan, B.S.
Stefanie was welcomed to the Millman Lab in May 2016 having graduated with a B.S. degree in Biomedical Engineering from Washington University in St. Louis. She is now moving forward in pursuit of her M.S. in Biomedical Engineering. Her hobbies include running, cooking, and reading..
Leonardo Velazco-Cruz, B.S.
Leonardo received his B.S. degree in Biology from California State University, Fresno. He joins the Millman Lab on January 2017 as a predoctoral candidate seeking to generate advancements in stem cell technology and diabetes pathogenesis. Leonardo’s leisure time include rock climbing, running, and trying new foods..
Kristina Maxwell, B.S.
Kristina earned a B.S. in Biomedical Engineering from the University of Arkansas. She was accepted to the Biomedical Engineering PhD program at Washington University in St. Louis in the next fall and started a rotation in the Millman Lab in January 2017. She is interested in the development of stem cell technology to treat and model diabetes using SC-β cells. When not in the lab, Kristina enjoys participating in intramural sports with her classmates, running in Forest Park, and summer musicals at the Muny.
Emmy Mai, BS
Medical Student/Research Assistant
Emmy joined the Millman Lab in June of 2017 as a NIDDK program student. She has recently finished her first year of medical school at Saint Louis University’s School of Medicine and completed her undergraduate degree, BS in Biochemistry, minoring in Mathematics, at Saint Louis University. When not in lab, Emmy enjoys jogging, hiking, playing the piano, and reading.
Sara is an undergraduate student working toward a B.S. in Biomedical Engineering and a minor in Psychological & Brain Sciences at Washington University in St. Louis. On campus, she is involved in a variety of organizations, including the Executive Board of WUSTL’s Relay for Life Steering Committee. She enjoys reading, exploring the outdoors, and cooking. She joined the Millman Lab in January of 2017 and hopes to attend medical school in the future.
Anurima is an undergraduate student majoring in Biomedical Engineering and minoring in Computer Science at Washington University in St. Louis. She is very involved with the Society of Women Engineers, Ashoka (a South Asian Cultural group) and Wash U Garba (an Indian Dance Team). She is also going to be a Residential Advisor for the 2017-2018 and 2018-2019 school years. She began working in the Millman Lab in February of 2017.
Lisa is an undergraduate at Missouri University of Science and Technology, where she is majoring in Biological Science and minoring in Chemistry and Biomedical Engineering. She joins the Millman Lab in June 2017 as part of the Amgen Scholars Summer Program. When not in lab she is involved in Phi Sigma (a Biological Sciences honors Society) and Kappa Delta Sorority.
Jiwon Song, B.S.
Jiwon joined the Millman Lab in September 2015 after receiving her B.S. degree in Biomedical Engineering from Washington University in St. Louis. She hopes to attend graduate school in the near future. When she is not working in the lab, Jiwon enjoys swimming, playing the cello, and exploring new parts of the city.
Dr. Millman selected as one of AIChE’s 35 Under 35!
August 8th, 2017
Jeffrey R. Millman, PhD, assistant professor of medicine and biomedical engineering was awarded the American Institute of Chemical Engineering (AIChE) 35 Under 35 award. AIChE is the world’s leading organization for chemical engineering professionals, with more than 50,000 members from over 100 countries.
The award was created to acknowledge the successes of some of AIChE’s youngest members, all under the age of 35, and to promote the achievements of this generation of chemical engineers who are changing the face of the profession. Each award winner was selected for their achievements in one of seven categories: bioengineering, chemicals, education, energy, innovation, leadership, and safety.
Millman’s research lab uses stem cells in diabetes and regenerative medicine research. He is proud of the work he and his research team are doing in generating insulin-producing tissues in bioreactors, saying, “transplantation of these engineered tissues will one day replace the need for insulin injections in diabetes patients.” Millman has embraced the apprehension that comes with trying something new, like cutting-edge research, advising others to do the same and “move forward, confident that your failures will lead to growth and success.”
(portions of this originally published on WUSLT Endocrinology and AIChE CEP Magazine websites)
STEM education outreach event in partnership with JDRF
August 7th, 2017
The Millman lab was honored to bring in local type 1 diabetic children to visit his diabetes and stem cell research lab. Dr. Millman partnered with JDRF to develop this outreach event to encourage STEM education in young children. The children were able to see active stem cell differentiations and experiments, the laboratory space, and large research equipment. The importance of lab safety was discussed, with each children being able to wear lab glasses, lab coats, and gloves. Questions on science, technology, and STEM education were answered. We concluded with a speed pipetting competition. We really enjoyed our visitors and hope that they had fun! A special thank you to Dr. Nathaniel Hogrebe, Leonardo Velazco-Cruz, Anurima Sharma, and Kristina Maxwell from the Millman lab and Dr. Amy Clark and Dr. Steven Stone from the Urano lab for helping along with JDRF!
Millman Lab BBQ saying farewell to our summer students!
July 30, 2017
Thank you Leo, Nathaniel, Kristina, Stefanie, Anu, Lisa, and Emmy!
The lab receives NIH R01 funding
July 1, 2017
The lab has received its first NIH R01 funding for a project entitled “Studying the Role of the Microenvironment on Differentiation and Maturation of Beta Cells”. We hope that by studying the local microenvironment of our stem cell-derived β cells, particularly introducing microenvironmental cues normally found in the islet, that we will improve our protocol to make stem cell-derived β cells.
Dr. Millman presented his research at the American Diabetes Association (ADA) 77th Scientific Sessions on cellular therapy to manage diabetes.
June 9, 2017
Research Highlighted in KAIMRC Innovations
May 22, 2017
Dr. Millman recently gave an interview to KAIMRC Innovations, an international biomedical science magazine, describing the lab’s work developing a cellular therapy to treat diabetes.
Published new article reviewing the current state of manufacturing autologous β from diabetic patients for cellular therapy
May 5, 2017
Dr. Millman authored a review article published this month in the American Diabetes Association (ADA) journal Diabetes entitled “Autologous Pluripotent Stem Cell-Derived β-Like Cells for Diabetes Cellular Therapy”. This article discusses the state-of-the-art in stem cell technology for treating diabetes by replacing dead or dysfunctional insulin-producing β cells with cells manufactured in the laboratory. Included his discusses the major advances made in recent years along with the remaining major challenges that still face this approach. It is the hope of Dr. Millman and other researchers, including co-author Felicia Pagliuca, Ph.D., VP of Cell Biology Research and Development at Semma Therapeutics, that transplantation of these cells can alleviate symptoms of diabetes and replace the need for insulin injections.
Millman Lab outing to Basso to celebrate this semester’s successes!
May 1, 2017
Thank you Jiwon, Nathaniel, Stefanie, Kristina, Leo, Anu, and Sara for a wonderful semester!
Congratulations to Stefanie Shahan for successfully defending her master’s thesis!
April 26, 2017
Dr. Millman Receives Career Development Award from JDRF
April 20, 2017
Jeffrey R. Millman, PhD, an assistant professor of medicine in the Division of Endocrinology Metabolism & Lipid Research at Washington University School of Medicine in St. Louis, has received a 2017 Career Development Award from the Juvenile Diabetes Research Foundation (JDRF). Millman, also an assistant professor of biomedical engineering, will use the $750,000 grant to continue his work on new approaches for treating diabetes. He and his colleagues have developed a six-step process for generating functional, insulin-secreting beta cells from human stem cells. The eventual hope is to be able to use a person’s own stem cells to produce cells that secrete insulin when glucose levels rise, potentially helping patients with diabetes keep blood sugar levels in check without the need for insulin injections.
The Millman lab welcomes Anurima Sharma to the group as an undergraduate researcher!
The Millman lab welcomes Leonardo Velazco-Cruz to the group as a Division of Biology & Biomedical Sciences Ph.D. student!
January 23, 2017
The Millman lab welcomes Kristina Maxwell to the group as a Biomedical Engineering Ph.D. rotation student and Sara Arfania as an undergraduate researcher!
January 16, 2017
Research from the Millman laboratory highlighted by NIH NIDDK
December 27, 2016
Making beta cells from people with type 1 diabetes
Published new article showcasing a 3D-printing approach for transplantation of stem cell-derived β-like cells
December 1, 2016
We congratulate Jiwon Song on her first first-authorship publication that just came out in Biofabrication entitled “Economic 3D-printing approach for transplantation of human stem cell-derived β-like cells” demonstrating a 3D-printing approach for fabricating a macroporous and retrievable transplantation device. This research could someday be used to deliver stem cell-derived β-like cells for cell replacement therapy in diabetes.
The Millman lab welcomes Dr. Nathaniel Hogrebe to the group as a postdoctoral research fellow!
November 1, 2016.
Dr. Millman issued a new patent entitled “Method for differentiating human embryonic stem cells into β-cells for treatment of type I diabetes”, patent number 9,447,378.
September 20, 2016.
Dr. Millman issued a new patent entitled “Methods and compositions for increased safety of stem cell-derived populations”, patent number 9,388,381.
July 12, 2016.
The Millman lab welcomes Stefanie Shahan to the group as a Biomedical Engineering M.S. student!
June 6, 2016.
Published new article generating stem cell-derived β cells from Type 1 diabetic patients
May 10, 2016
We have published an article with Harvard University colleagues in Nature Communications entitled “Generation of stem cell-derived β-cells from patients with type 1 diabetes” demonstrating extension of our prior method for making stem cell-derived β cells to diabetic patients. This research will open up the potential for autologous cell replacement therapy in diabetes and the further development of diabetes disease modeling for drug screening.
Encapsulation of stem cell-derived beta cells controls blood glucose in immune-competent mice
January 25, 2016
Dr. Jeffrey Millman was co-author on a report published in Nature Medicine entitled “Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice”.
Missouri Researcher Spotlight of Dr. Jeffrey Millman’s research is in the October 2015 Missouri Cures Education Foundation newsletter
October 31, 2015
Semma Therapeutics founded based on technology Dr. Jeffrey Millman developed with colleagues at Harvard University.
March 24, 2015
Dr. Jeffrey Millman was interviewed in an article published by The Pharmaceutical Journal entitled “Making β cells in the laboratory”.
February 10, 2015
Dr. Jeffrey Millman’s research making stem cell-derived β cells was named one of the top 10 breakthroughs of 2014 by Science Magazine
December 19, 2014
Production of functional stem cell-derived β cells from human stem cells
October 9, 2014
Dr. Jeffrey Millman was co-first author with colleagues at Harvard University in a report published in Cell entitled “Generation of Functional Human Pancreatic β Cells In Vitro” demonstrating a strategy for producing functional stem cell-derived β cells from human embryonic stem cells and induced pluripotent stem (iPS) cells.
- Patient Care
- Our People
- Clinical Studies
- Core Services